Cargando…

T Helper 17 Cells in Primary Sjögren’s Syndrome

Primary Sjögren’s syndrome is an autoimmune disease characterized by diffuse infiltration of lymphocytes into exocrine glands and other tissues. The infiltrating lymphocytes have been identified as subsets of B cells and T cells, including T helper 17 cells, T regulatory cells and follicular helper...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsui, Kiyoshi, Sano, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532573/
https://www.ncbi.nlm.nih.gov/pubmed/28678161
http://dx.doi.org/10.3390/jcm6070065
_version_ 1783253485026803712
author Matsui, Kiyoshi
Sano, Hajime
author_facet Matsui, Kiyoshi
Sano, Hajime
author_sort Matsui, Kiyoshi
collection PubMed
description Primary Sjögren’s syndrome is an autoimmune disease characterized by diffuse infiltration of lymphocytes into exocrine glands and other tissues. The infiltrating lymphocytes have been identified as subsets of B cells and T cells, including T helper 17 cells, T regulatory cells and follicular helper T cells. The role of these cells in the development of the syndrome is now known, as is their impact on the production of proinflammatory cytokines such as IL-6, IL-17, IL-22 and IL-23. In particular, experimental animal models and patients suggest that a shift in Th17/Treg balance toward the proinflammatory Th17 axis exacerbates primary Sjögren’s syndrome and other autoimmune disorders. Nevertheless, the pathogenesis of the disorder is not yet fully elucidated. This review summarizes the recent advances in therapeutic control of the Treg/Th17 balance, as well as the efficacy of candidate therapeutics against primary Sjögren’s syndrome.
format Online
Article
Text
id pubmed-5532573
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-55325732017-08-08 T Helper 17 Cells in Primary Sjögren’s Syndrome Matsui, Kiyoshi Sano, Hajime J Clin Med Review Primary Sjögren’s syndrome is an autoimmune disease characterized by diffuse infiltration of lymphocytes into exocrine glands and other tissues. The infiltrating lymphocytes have been identified as subsets of B cells and T cells, including T helper 17 cells, T regulatory cells and follicular helper T cells. The role of these cells in the development of the syndrome is now known, as is their impact on the production of proinflammatory cytokines such as IL-6, IL-17, IL-22 and IL-23. In particular, experimental animal models and patients suggest that a shift in Th17/Treg balance toward the proinflammatory Th17 axis exacerbates primary Sjögren’s syndrome and other autoimmune disorders. Nevertheless, the pathogenesis of the disorder is not yet fully elucidated. This review summarizes the recent advances in therapeutic control of the Treg/Th17 balance, as well as the efficacy of candidate therapeutics against primary Sjögren’s syndrome. MDPI 2017-07-05 /pmc/articles/PMC5532573/ /pubmed/28678161 http://dx.doi.org/10.3390/jcm6070065 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Matsui, Kiyoshi
Sano, Hajime
T Helper 17 Cells in Primary Sjögren’s Syndrome
title T Helper 17 Cells in Primary Sjögren’s Syndrome
title_full T Helper 17 Cells in Primary Sjögren’s Syndrome
title_fullStr T Helper 17 Cells in Primary Sjögren’s Syndrome
title_full_unstemmed T Helper 17 Cells in Primary Sjögren’s Syndrome
title_short T Helper 17 Cells in Primary Sjögren’s Syndrome
title_sort t helper 17 cells in primary sjögren’s syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532573/
https://www.ncbi.nlm.nih.gov/pubmed/28678161
http://dx.doi.org/10.3390/jcm6070065
work_keys_str_mv AT matsuikiyoshi thelper17cellsinprimarysjogrenssyndrome
AT sanohajime thelper17cellsinprimarysjogrenssyndrome